Profiling the Distribution of N-Glycosylation in Therapeutic Antibodies

Profiling the Distribution of N-Glycosylation in Therapeutic Antibodies

Download your copy...

 

Immunoglobulin G molecules have become attractive as targeted therapeutic proteins, due to their high specificity and long circulation time. Glycosylation patterns determine the stability and bio-disposition of these recombinant protein drugs in vivo, as well as the efficacy, folding, binding affinity, specificity and pharmacokinetic properties. Therefore, a complete characterization of the biotherapeutic IgG glycosylation is desirable.

In this study, we demonstrated how a comprehensive MS/MS analysis of the glycopeptides can be achieved by targeting the known nature of the glycosylation structures.

To download your copy of this application note complete the form opposite.

Registrants for this application note are covered by the Eclipse Business Media Privacy Policy.